IR, defined by a diminished responsiveness of insulin-sensitive tissues to physiological insulin levels, is a key contributor to numerous conditions, such as ischemic stroke, type 2 diabetes mellitus, atherosclerosis, and metabolic syndrome (9–11). This evidence concerns the gene INS and diabetes mellitus.